Intravascular tumor extension, also known as tumor thrombus, can occur in many different
types of cancer. Those with the highest proclivity include Wilm's tumor, renal cell carcinoma …

Abstract Background: The Barcelona Clinic Liver Cancer (BCLC) intermediate and
advanced stages (BCLC B and C) of hepatocellular carcinoma (HCC) both include …

Introduction: Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer
and the third leading cause of cancer death worldwide. While there has been rapid evolution …

The Barcelona Clinic Liver Cancer (BCLC) advanced stage (BCLC C) of hepatocellular
carcinoma (HCC) includes a heterogeneous population, where sorafenib alone is the …

Abstract Background and Aims Different approaches are available after the progression of
disease (PD) to immune checkpoint inhibitors (ICIs) for hepatocellular carcinoma (HCC) …

Background We hypothesized that portal vein tumor thrombosis (PVTT) in hepatocellular
carcinoma (HCC) increases portal pressure and causes esophageal varices and variceal …

Abstract Background & Aims Several staging systems have been proposed for
hepatocellular carcinoma (HCC). Among them, only the Barcelona Clinic Liver Cancer …

Hepatocellular carcinoma (HCC) is one of the most common malignancies and a leading
cause of cancer-related death worldwide. Surgery remains the primary and most successful …

Cancer is a major cause of global mortality, both in affluent countries and increasingly in
developing nations. Many patients with cancer experience reduced life expectancy and …

Although the current standard treatment for hepatocellular carcinoma (HCC) with portal vein
tumor thrombosis (PVTT) is sorafenib, many previous studies have established the need for …